CGRP
CGRP (calcitonin gene related peptide) is a potent peptide vasodilator and can function in the transmission of pain.
Products for CGRP
- Cat.No. Product Name Information
- GC34944 β-CGRP, human TFA
- GC33595 β-CGRP, human (Human β-CGRP) β-CGRP, human (Human β-CGRP) (Human β-CGRP) is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells.
- GC34230 Adrenomedullin (1-50), rat Adrenomedullin (1-50), rat is a 50 amino acid peptide, which induces a selective arterial vasodilation via activation of CGRP1 receptor.
- GC35256 Adrenomedullin (11-50), rat Adrenomedullin (11-50), rat is the C-terminal fragment (11-50) of rat adrenomedullin.
- GC35257 Adrenomedullin (16-31), human Adrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).
- GC32615 Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human)) Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human)), an NH2 terminal truncated adrenomedullin analogue, is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat.
- GC65596 Atogepant Atogepant (MK-8031) is an orally active and selective calcitonin gene–related peptide receptor (CGRP) antagonist.
- GC13705 BMS-927711 A CGRP receptor antagonist
- GC50320 Calcitonin (human) Endogenous calcitonin agonist; inhibits bone resorption
- GC34396 Calcitonin Gene Related Peptide (CGRP) (83-119), rat
- GC34395 Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA
- GC32851 Calcitonin salmon (Salmon calcitonin) Calcitonin salmon, a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption.
- GC16147 CGRP 8-37 (human) CGRP 8-37 (human) is a human calcitonin gene-related peptide (hCGRP) fragment and also an antagonist of CGRP receptor.
- GC10927 CGRP 8-37 (rat) CGRP 8-37 (rat) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist.
- GC31107 CGRP antagonist 1 CGRP antagonist 1 is a highly potent CGRP receptor antagonist with a Ki and IC50 of 35 and 57 nM, respectively.
- GC66408 Fremanezumab Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research.
- GC66402 Galcanezumab Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research.
- GC18501 Kendomycin Kendomycin is a macrolide from Streptomyces which displays potent cytotoxicity against several carcinoma cell lines (GI50 < 100 nM).
- GC16478 MK-0974 A CGRP receptor antagonist
- GC16365 MK-3207
- GC11192 MK-3207 HCl MK-3207 (Hydrochloride) is a potent and orally bioavailable CGRP receptor antagonist with IC50 of 0.12 nM and Ki of 0.024 nM, and is highly selective versus human AM1, AM2, CTR, and AMY3.
- GC17233 Olcegepant
- GC36795 Olcegepant hydrochloride Olcegepant hydrochloride (BIBN-4096 hydrochloride) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP.
- GC15348 Pyridostigmine Bromide Reversible cholinesterase inhibitor
- GC30341 Ubrogepant (MK-1602) Ubrogepant (MK-1602) (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.
- GC62199 Vazegepant hydrochloride Vazegepant (BHV-3500) hydrochloride is a highly soluble CGRP receptor antagonist (hCGRP Ki= 0.023 nM).